IONS

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) is a biotechnology company founded in 1989 and headquartered in Carlsbad, California. The company went public in 1991 and has established itself as a pioneer in RNA-targeted therapeutics, developing medicines that work by targeting specific RNA molecules to treat various diseases. Over its 35-year history, Ionis has evolved from a research-focused organization into a commercial-stage biopharmaceutical company with multiple approved drugs and a robust pipeline of late-stage development programs. The company has successfully launched several medicines independently and through partnerships, generating revenue from both product sales and royalties from partner-commercialized drugs.